Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 10 04:00PM ET
3.59
Dollar change
-0.11
Percentage change
-2.97
%
Index- P/E- EPS (ttm)-6.66 Insider Own- Shs Outstand3.33M Perf Week-27.33%
Market Cap11.95M Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month-37.46%
Income-17.57M PEG- EPS next Q- Inst Own6.61% Short Float- Perf Quarter-1.83%
Sales1.52M P/S7.86 EPS this Y- Inst Trans-36.62% Short Ratio0.24 Perf Half Y36.97%
Book/sh-2.01 P/B- EPS next Y- ROA-106.15% Short Interest0.03M Perf Year-10.25%
Cash/sh0.33 P/C10.77 EPS next 5Y- ROE-2639.52% 52W Range1.87 - 15.80 Perf YTD-18.32%
Dividend Est.- P/FCF- EPS past 5Y11.47% ROI- 52W High-77.28% Beta2.00
Dividend TTM- Quick Ratio0.24 Sales past 5Y-20.00% Gross Margin-81.72% 52W Low92.39% ATR (14)0.63
Dividend Ex-Date- Current Ratio0.24 EPS Y/Y TTM19.58% Oper. Margin-1237.36% RSI (14)32.57 Volatility16.17% 13.38%
Employees- Debt/Eq- Sales Y/Y TTM- Profit Margin-1156.92% Recom1.00 Target Price20.00
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q-109.13% Payout- Rel Volume1.01 Prev Close3.70
Sales Surprise- EPS Surprise- Sales Q/Q- EarningsAug 29 Avg Volume146.43K Price3.59
SMA20-29.56% SMA50-28.89% SMA200-4.59% Trades Volume148,447 Change-2.97%
Date Action Analyst Rating Change Price Target Change
Oct-14-21Initiated Maxim Group Buy $18
Jan-05-21Initiated H.C. Wainwright Buy $17
Nov-04-24 07:30AM
Oct-16-24 07:27AM
Oct-15-24 07:32AM
Oct-02-24 08:45AM
Sep-23-24 08:30AM
07:30AM Loading…
Sep-12-24 07:30AM
Jul-31-24 09:53AM
07:00AM
Jul-25-24 06:10AM
Jul-12-24 11:24AM
10:08AM
07:41AM
Jul-11-24 01:26PM
01:01PM
12:51PM
12:31PM Loading…
12:31PM
07:29AM
06:32AM
Jul-10-24 12:42PM
12:08PM
11:57AM
07:30AM
Jun-27-24 08:15AM
May-23-24 02:41PM
May-21-24 07:39AM
May-02-24 04:22AM
May-01-24 08:45AM
Mar-24-24 07:55AM
Mar-21-24 08:52AM
Mar-13-24 08:00AM
07:30AM Loading…
Feb-21-24 07:30AM
Jan-18-24 07:30AM
Dec-05-23 06:02PM
Dec-01-23 08:00AM
Nov-29-23 07:01AM
Nov-21-23 07:30AM
Nov-20-23 04:30PM
Nov-15-23 08:30AM
Nov-10-23 07:01AM
Nov-01-23 07:01AM
Oct-23-23 07:01AM
Oct-11-23 07:01AM
Oct-05-23 07:01AM
Sep-29-23 07:01AM
Jul-06-23 07:00AM
Jun-08-23 07:00AM
May-25-23 07:01AM
Apr-14-23 07:01AM
Apr-04-23 07:00AM
Jan-25-23 03:03PM
Jan-18-23 11:50AM
Jan-16-23 07:01AM
Dec-19-22 09:00PM
Dec-15-22 07:01AM
Dec-12-22 07:01AM
Dec-01-22 07:01AM
Nov-28-22 04:50PM
Nov-09-22 07:00AM
Nov-02-22 07:10AM
Oct-27-22 10:48AM
07:00AM
Oct-06-22 08:00AM
Sep-26-22 09:55AM
Sep-09-22 08:00AM
Sep-08-22 06:00PM
Sep-07-22 10:35AM
Aug-11-22 09:55AM
Aug-05-22 10:00AM
08:40AM
Aug-01-22 07:00AM
Jul-17-22 06:28PM
Jul-12-22 08:15AM
Jul-06-22 07:00AM
Jun-17-22 08:00AM
Jun-13-22 07:00AM
Jun-08-22 08:49PM
Jun-07-22 07:00AM
Jun-03-22 07:00AM
May-31-22 07:00AM
May-26-22 07:50AM
May-23-22 08:30AM
May-17-22 08:00AM
May-16-22 09:12PM
Apr-29-22 11:00AM
Apr-08-22 08:30AM
08:00AM
Mar-30-22 07:35AM
Mar-28-22 05:46AM
Mar-21-22 08:00AM
Feb-28-22 08:00AM
Feb-07-22 02:25PM
08:00AM
Jan-25-22 08:00AM
Jan-07-22 08:00AM
Dec-24-21 02:33PM
Dec-13-21 11:00AM
Dec-04-21 08:00AM
Nov-29-21 08:00AM
Nov-28-21 09:47PM
Nov-15-21 11:00AM
Kazia Therapeutics Ltd. is an oncology-focused biotechnology company, which engages in the business of pharmaceutical drug development. The company was founded by Graham Edmund Kelly in March 1994 and is headquartered in Sydney, Australia.